Literature DB >> 8673907

p53 activity and chemotherapy.

D Delia, S Mizutani, G Lamorte, K Goi, S Iwata, M A Pierotti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8673907     DOI： 10.1038/nm0796-724

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  6 in total

1.  Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53.

Authors:  M Müller; S Strand; H Hug; E M Heinemann; H Walczak; W J Hofmann; W Stremmel; P H Krammer; P R Galle
Journal:  J Clin Invest       Date:  1997-02-01       Impact factor: 14.808

2.  The role of Six1 signaling in paclitaxel-dependent apoptosis in MCF-7 cell line.

Authors:  Marzieh Armat; Taiebeh Oghabi Bakhshaiesh; Mehdi Sabzichi; Dariush Shanehbandi; Simin Sharifi; Ommoleila Molavi; Jamal Mohammadian; Mohammad Saeid Hejazi; Nasser Samadi
Journal:  Bosn J Basic Med Sci       Date:  2016-01-01       Impact factor: 3.363

3.  Mutation of the p53 gene in human astrocytic tumours correlates with increased resistance to DNA-damaging agents but not to anti-microtubule anti-cancer agents.

Authors:  Y Iwadate; M Tagawa; S Fujimoto; M Hirose; H Namba; K Sueyoshi; S Sakiyama; A Yamaura
Journal:  Br J Cancer       Date:  1998-02       Impact factor: 7.640

4.  Inactivation of wild-type p53 by a dominant negative mutant renders MCF-7 cells resistant to tubulin-binding agent cytotoxicity.

Authors:  C M Galmarini; N Falette; E Tabone; C Levrat; R Britten; N Voorzanger-Rousselot; O Roesch-Gateau; A Vanier-Viornery; A Puisieux; C Dumontet
Journal:  Br J Cancer       Date:  2001-09-14       Impact factor: 7.640

Review 5.  The Tip of an Iceberg: Replication-Associated Functions of the Tumor Suppressor p53.

Authors:  Vanesa Gottifredi; Lisa Wiesmüller
Journal:  Cancers (Basel)       Date:  2018-07-28       Impact factor: 6.639

6.  Therapy effect of either paclitaxel or cyclophosphamide combination treatment in patients with epithelial ovarian cancer and relation to TP53 gene status.

Authors:  B Smith-Sørensen; J Kaern; R Holm; A Dørum; C Tropé; A L Børresen-Dale
Journal:  Br J Cancer       Date:  1998-08       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.